Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Allogeneic'

Allogeneic published presentations and documents on DocSlides.

Allogeneic
Allogeneic
by trish-goza
Stem Cell Transplantation in 2011 (and beyond?)....
27Patient Blood Management Guidelines
27Patient Blood Management Guidelines
by wang
Preoperative autologous blood donation (PAD) is th...
Long-Term Reduction in Peripheral Blood HIV-1 Reservoirs Fo
Long-Term Reduction in Peripheral Blood HIV-1 Reservoirs Fo
by yoshiko-marsland
Reduced-Intensity . Allogeneic. Stem Cell Transp...
Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT)
Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT)
by ellena-manuel
Location of Centers Participating. in the CIBMTR ...
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
by cheryl-pisano
Location of Centers Participating. in the CIBMTR ...
Collection of Survival and Clinical Data
Collection of Survival and Clinical Data
by tawny-fly
Collection of Survival and Clinical Data for Mul...
Lessons learned from Phase 1 trial of heart-derived stem
Lessons learned from Phase 1 trial of heart-derived stem
by alexa-scheidler
Lessons learned from Phase 1 trial of heart-der...
Benefits of autotransfusion
Benefits of autotransfusion
by luanne-stotts
Overview. . of. . applications. & . indica...
Allogeneic donor selection and blood collection
Allogeneic donor selection and blood collection
by calandra-battersby
by Mohammed Abu-. basha. 1. An . allogeneic. . (...
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
by alida-meadow
Location of Centers Participating. in the CIBMTR ...
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013
by lois-ondreau
Location of Centers Participating. in the CIBMTR ...
Tailoring Reduced-Intensity
Tailoring Reduced-Intensity
by eurolsin
Conditioning: . Applying Emerging Evidence to Clin...
SCREENING ALLOGENEIC BLOOD DONORS FOR PULSE RATE
SCREENING ALLOGENEIC BLOOD DONORS FOR PULSE RATE
by joyce
ABNORMALITIES DOES IT PREVENT CARDIAC ISCHEMIC EVE...
The Role of Bone Marrow Transplant in Oncology
The Role of Bone Marrow Transplant in Oncology
by elyana
Diane Hill-Polerecky RN, BSN, MS. Leukemia Transpl...
COVID-19 Percentage of CRS
COVID-19 Percentage of CRS
by Thunderbolt
clinical. . symptoms. Allo. -HSCT. Fever. Erythro...
Who, when and how to transplant
Who, when and how to transplant
by LadyInRed
adults with . AML. Prof C Craddock CBE. Queen Eliz...
AutologousBloodDonationinCardiacSurgeryReductionofAllogeneicBloodTran
AutologousBloodDonationinCardiacSurgeryReductionofAllogeneicBloodTran
by jasmine
fusionrequirementsinpatientsundergoingcardiacsurge...
PRODUCT LIST KEUM CHEONG PHARM
PRODUCT LIST KEUM CHEONG PHARM
by piper
▣ . Cosmetics. QUEENFEI. 　. 　. 　. QUEENFEI...
UCART20X22: ALLOGENEIC DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
UCART20X22: ALLOGENEIC DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
by melanie
June 2. nd. 2023. Roman Galetto, PhD. Preclinical...
Common Barriers to Replicability and Retrieval in Systematic Review Search Strategies
Common Barriers to Replicability and Retrieval in Systematic Review Search Strategies
by arya
Whitney A Townsend, MLIS. Patricia F Anderson, MIL...
We are now listed on NASDAQ
We are now listed on NASDAQ
by tracy
. CytoMed Therapeutics Limited . (Stock code :GDTC...
TRANSPLANTUL ALLOGENEIC
TRANSPLANTUL ALLOGENEIC
by hailey
DE C. ELULE STE. M HEMATOPOIETICE. : . ALEGEREA DO...
Hosted by Blood & Marrow Transplant Information Network (BMT
Hosted by Blood & Marrow Transplant Information Network (BMT
by oryan
InfoNet. ). Wednesday, October 27, 2021. Transplan...
AAMAC - HSCT Lynn Savoie
AAMAC - HSCT Lynn Savoie
by willow
October 19, 2019. Process of Hematopoietic Stem Ce...
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
by cesar673
+. Peripheral T-Cell Lymphoma: A Phase 2 Study (L...
ADHOC: Assessing Deviations for HPCs Obtained during COVID-19
ADHOC: Assessing Deviations for HPCs Obtained during COVID-19
by charlie817
H. PCs . O. btained during . C. OVID-19 . John . G...